<DOC>
	<DOC>NCT03103880</DOC>
	<brief_summary>The purpose of the study is to determine the feasibility and acceptability of at-home use of the Cohero mHealth (mobile health) technology, which consists of a Bluetooth Low Energy connected medication-use sensor (HerotrackerTM) that monitors at-home medication use, mobile application (BreatheSmart) that sends real-time reminders, and mobile spirometer (mSpirometer) that measures lung function, through a virtual observational study format in order to improve patient engagement with the platform for sustainable use and motivate subjects to self-manage their disease.</brief_summary>
	<brief_title>Assessing the Use of Mobile Technology in Adult Asthma Patients</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Ability to provide written informed consent Male and female adults (aged â‰¥ 18 years) Diagnosis of asthma for at least 6 months ICS (inhaled corticosteroid) use for at least 3 months Use of a pressurized metered dose inhaler (pMDI) compatible with the Cohero mHealth HerotrackerTM Possess a compatible smartphone (iOS 8.0 or higher and Android 4.3 or higher) Currently pregnant or planning to become pregnant during the study period Primary language other than English (BreatheSmart mobile app is currently available only in English)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Patient Adherence</keyword>
	<keyword>Mobile Applications</keyword>
	<keyword>Mobile Health</keyword>
</DOC>